![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
Chemical and physical data | |
Formula | C24H23ClN6O2 |
Molar mass | 462.94 g·mol−1 |
3D model (JSmol) | |
| |
|
PSB-KK1415 is an experimental drug that acts as a potent and selective agonist for the cannabinoid-like NAGly receptor, also known as GPR18. It has potential applications in studying the immune system and development of cancer. [1]